Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The document explains various skin conditions and their treatments.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Cetuximab can cause eyelash growth, which is rare but manageable.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Skin reactions from cancer treatments might predict how well the treatments work.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A man developed skin issues from cancer medication, which improved with specific treatments.

Older men with lower levels of available testosterone are more likely to be frail.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.